Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study findings reveal racial and ethnic disparities in access to neurologic health care

Study findings reveal racial and ethnic disparities in access to neurologic health care

Newly identified biomarkers could help predict cognitive deficits in Parkinson's disease patients

Newly identified biomarkers could help predict cognitive deficits in Parkinson's disease patients

WPI research program aims to understand gender differences in neurobiology

WPI research program aims to understand gender differences in neurobiology

Small molecules in saliva show potential for early diagnosis of Alzheimer's disease

Small molecules in saliva show potential for early diagnosis of Alzheimer's disease

‘Disease in a dish’ model pinpoints how defects in blood-brain barrier can cause psychomotor disorder

‘Disease in a dish’ model pinpoints how defects in blood-brain barrier can cause psychomotor disorder

Research findings could potentially improve early diagnosis of Alzheimer's disease

Research findings could potentially improve early diagnosis of Alzheimer's disease

Scientists use AHDS patients’ cells to recreate disease and mimic blood-brain barrier

Scientists use AHDS patients’ cells to recreate disease and mimic blood-brain barrier

Novel app that predicts manic, depressive episodes in people with bipolar disorder wins grand prize

Novel app that predicts manic, depressive episodes in people with bipolar disorder wins grand prize

Physical activity can help prevent, manage Alzheimer's disease and other dementias

Physical activity can help prevent, manage Alzheimer's disease and other dementias

Researchers measure spread of tau protein in the brains of Alzheimer’s patients

Researchers measure spread of tau protein in the brains of Alzheimer’s patients

JAX researcher awarded federal grant for genomic studies of healthy aging and Alzheimer's disease

JAX researcher awarded federal grant for genomic studies of healthy aging and Alzheimer's disease

Scientists discover potential brain imaging predictor for early dementia

Scientists discover potential brain imaging predictor for early dementia

Elevated levels of specific protein linked to increased risk of ischemic stroke among women

Elevated levels of specific protein linked to increased risk of ischemic stroke among women

Virtual reality support group could be effective option for older adults who have lost a spouse

Virtual reality support group could be effective option for older adults who have lost a spouse

Personalized music may benefit seniors with dementia living in nursing homes

Personalized music may benefit seniors with dementia living in nursing homes

Low BMI may not be causal risk factor for Alzheimer's disease

Low BMI may not be causal risk factor for Alzheimer's disease

‘Boot Camp’ helps Alzheimer’s, dementia caregivers take care of themselves, too

‘Boot Camp’ helps Alzheimer’s, dementia caregivers take care of themselves, too

Study findings suggest how progranulin deficiency causes frontotemporal dementia

Study findings suggest how progranulin deficiency causes frontotemporal dementia

New cell-separation technique could revolutionize vital therapies for life-threatening diseases

New cell-separation technique could revolutionize vital therapies for life-threatening diseases

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.